Smith & Nephew Snats (SNN) has released an update. Smith & Nephew reported a 4% revenue growth in Q3 2024, reaching $1,412 million, ...

Smith & Nephew Snats (SNN) has released an update. Smith & Nephew reported a 4% revenue growth in the third quarter of 2024, reaching ...

Hip and knee implant maker Smith & Nephew has cut its full-year guidance as it continues to grapple with a slowdown in China.

Smith+Nephew (NYSE:SNN) shares took a hit today on third-quarter results that highlighted ongoing struggles in China.

This FTSE 100 share plunged today, leaving our writer to wonder if there's an enticing value stock staring him right in the ...

Shares in Smith & Nephew tumbled on Thursday, after the medical devices firm slashed its full-year sales guidance on ...

After a few tough years blighted by the pandemic, the outlook might be getting a bit brighter for the Smith & Nephew share ...

Smith & Nephew Plc engages in the development ... Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses ...

Costantino Cagimanolis, senior vice president, advanced wound management operations at Smith & Nephew, said the move would secure the company's "long-term future in the region". The new site will ...

Smith & Nephew plc engages in the development ... Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses ...

Detailed price information for Smith & Nephew Snats ADR (SNN-N) from The Globe and Mail including charting and trades.